4.5 Article

A standardised protocol for relative SARS-CoV-2 variant severity assessment, applied to Omicron BA.1 and Delta in six European countries, October 2021 to February 2022

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Microbiology

Rapid and Flexible RT-qPCR Surveillance Platforms To Detect SARS-CoV-2 Mutations

Katja Spiess et al.

Summary: This study describes the design of a large-scale RT-qPCR platform and a flexible small-scale RT-qPCR platform to detect SARS-CoV-2 variants, supporting the control of SARS-CoV-2 in Denmark.

MICROBIOLOGY SPECTRUM (2023)

Article Multidisciplinary Sciences

The effect of SARS-CoV-2 variant on respiratory features and mortality

Thomas D. Hughes et al.

Summary: This study aimed to determine the impact of SARS-CoV-2 variants on respiratory features, mortality, and vaccination status. A retrospective review of medical records was conducted to identify the effects of vaccination status on survival and respiratory features. The study found increased odds of death among unvaccinated individuals and those who were fully or partially vaccinated during multiple waves of the pandemic. Vaccination status was associated with a decreased frequency of respiratory features and improved survival. Recent SARS-CoV-2 variants showed a reduction in lower respiratory tract features and an increase in upper respiratory tract features.

SCIENTIFIC REPORTS (2023)

Article Infectious Diseases

Reduced risk of hospitalisation among reported COVID-19 cases infected with the SARS-CoV-2 Omicron BA.1 variant compared with the Delta variant, Norway, December 2021 to January 2022

Lamprini Veneti et al.

Summary: A study found that the Omicron variant of COVID-19 has a 73% reduced risk of hospitalization compared to the Delta variant. Omicron cases who had received two doses of the vaccine 7-179 days before diagnosis had a lower risk compared to Delta (66% vs 93%), while those who received three doses had a similar risk reduction (86% vs 88%).

EUROSURVEILLANCE (2022)

Article Infectious Diseases

No difference in risk of hospitalization between reported cases of the SARS-CoV-2 Delta variant and Alpha variant in Norway

Lamprini Veneti et al.

Summary: There was no difference in the risk of hospitalization between Delta variant cases and Alpha variant cases in Norway. Partially vaccinated and fully vaccinated cases had a lower risk of hospitalization compared to unvaccinated cases.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2022)

Letter Medicine, General & Internal

Estimates of SARS-CoV-2 Omicron Variant Severity in Ontario, Canada

Ana Cecilia Ulloa et al.

Summary: This study compares hospitalizations and deaths associated with SARS-CoV-2 Omicron variant to those of matched patients infected with the Delta variant.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

Article Medicine, General & Internal

Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study

Nicole Wolter et al.

Summary: According to data analysis from South Africa, individuals infected with the omicron variant have a lower likelihood of hospitalization compared to those infected with non-omicron variants. Furthermore, individuals infected with the omicron variant have a lower odds of severe disease compared to individuals infected with the earlier delta variant.

LANCET (2022)

Article Multidisciplinary Sciences

SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo

Kenrie P. Y. Hui et al.

Summary: SARS-CoV-2 variants pose a threat to global public health. The Omicron variant replicates faster in bronchi but less efficiently in the lung parenchyma compared to other variants. All variants of concern have similar cellular tropism.

NATURE (2022)

Letter Medicine, General & Internal

Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa

Shirley Collie et al.

Summary: Preliminary data from a test-negative study design in South Africa showed that two doses of the BNT162b2 vaccine had an efficacy of 50 to 70% against hospitalization caused by the omicron variant in Gauteng province.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Article Infectious Diseases

Enhancing epidemiological surveillance of the emergence of the SARS-CoV-2 Omicron variant using spike gene target failure data, England, 15 November to 31 December 2021

Paula B. Blomquist et al.

Summary: When SARS-CoV-2 Omicron emerged, the failure of the S gene target provided a way to differentiate it from the dominant Delta variant. In England, where S gene target surveillance was already in place, this led to quick identification of potential Omicron cases and real-time monitoring of its growth. The use of S gene target surveillance played a crucial role in public health measures, including case identification and incident management, and we provide practical insights on its application.

EUROSURVEILLANCE (2022)

Article Infectious Diseases

Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study

Katherine A. Twohig et al.

Summary: A study in England found that patients with COVID-19 infected with the delta variant were more likely to be admitted to hospital or attend emergency care compared to those infected with the alpha variant. This suggests that outbreaks of the delta variant in unvaccinated populations may pose a greater burden on healthcare services.

LANCET INFECTIOUS DISEASES (2022)

Article Medicine, General & Internal

Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study

Cristina Menni et al.

Summary: This study investigated the differences in symptom prevalence, risk of hospital admission, and symptom duration between omicron and delta variants of the SARS-CoV-2 virus. The study found that loss of smell was less common in omicron infections, sore throat was more common, and the rate of hospital admission was lower.

LANCET (2022)

Article Medicine, General & Internal

Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study

Tommy Nyberg et al.

Summary: The Omicron variant shows lower severity compared to Delta, especially in terms of hospital admission and death, with significant variations by age. Unvaccinated cases experience a larger reduction in intrinsic severity, while vaccinated cases experience reduced vaccine effectiveness. Booster vaccination with mRNA vaccines provides over 70% protection against hospitalization and death in breakthrough Omicron infections.

LANCET (2022)

Article Infectious Diseases

Risk of hospitalisation associated with infection with SARS-CoV-2 omicron variant versus delta variant in Denmark: an observational cohort study

Peter Bager et al.

Summary: This study aimed to estimate the risk of hospitalization after infection with the SARS-CoV-2 omicron variant compared with the delta variant in Denmark. The results showed that vaccination was associated with a lower risk of hospitalization, and Omicron infection was associated with a lower risk of hospitalization compared to Delta infection.

LANCET INFECTIOUS DISEASES (2022)

Article Biochemistry & Molecular Biology

Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2

Olha Puhach et al.

Summary: The infectious viral load of SARS-CoV-2 Omicron BA.1 is lower than that of Delta in breakthrough infections of vaccinated individuals. Vaccines may lower transmission risk and have a public health benefit.

NATURE MEDICINE (2022)

Letter Pediatrics

Incidence Rates and Clinical Outcomes of SARS-CoV-2 Infection With the Omicron and Delta Variants in Children Younger Than 5 Years in the US

Lindsey Wang et al.

Summary: This cohort study evaluates the incidence rates and clinical outcomes of SARS-CoV-2 infection caused by the Omicron and Delta variants in children younger than 5 years in the United States.

JAMA PEDIATRICS (2022)

Article Multidisciplinary Sciences

Viral load dynamics of SARS-CoV-2 Delta and Omicron variants following multiple vaccine doses and previous infection

Yonatan Woodbridge et al.

Summary: This study demonstrates that recent vaccination reduces Omicron viral load, but its effect wanes rapidly. In contrast, recovered COVID-19 individuals show a significantly slower waning rate. Therefore, a reassessment of future booster campaigns is needed.

NATURE COMMUNICATIONS (2022)

Article Biochemistry & Molecular Biology

Clinical outcomes associated with SARS-CoV-2 Omicron (B.1.1.529) variant and BA.1/BA.1.1 or BA.2 subvariant infection in Southern California

Joseph A. Lewnard et al.

Summary: Comparison of outcomes of SARS-CoV-2 Delta and Omicron infections reveals reduced severity of Omicron infections, especially in unvaccinated individuals. There is no differential risk of severe outcomes between subvariants BA.1 and BA.2. Continual assessment of clinical outcomes associated with SARS-CoV-2 variants is crucial for medical interventions and healthcare resource management.

NATURE MEDICINE (2022)

Article Pediatrics

COVID-19 Hospitalization Among Children <18 Years by Variant Wave in Norway

Robert Whittaker et al.

Summary: This study compared the risk of hospitalization for acute COVID-19 and MIS-C among children and adolescents in Norway infected with different variants of COVID-19. The findings suggest that the risk of hospitalization for acute COVID-19 was lower in the Delta and Omicron waves compared to the Alpha wave. Additionally, the risk of MIS-C was lower for Omicron compared to both Alpha and Delta.

PEDIATRICS (2022)

Article Health Care Sciences & Services

Adjusting for time of infection or positive test when estimating the risk of a post-infection outcome in an epidemic

Shaun R. Seaman et al.

Summary: When comparing the risk of a post-infection binary outcome between two variants of an infectious pathogen, it is crucial to adjust for the calendar time of infection. This study demonstrates that if the time from infection to positive test is correlated with the outcome, the risk ratio adjusted for positive test time can vary significantly from the risk ratio adjusted for infection time.

STATISTICAL METHODS IN MEDICAL RESEARCH (2022)

Article Infectious Diseases

Variation in reported SARS-CoV-2 cases after testing policy changes

Florence Halford et al.

LANCET INFECTIOUS DISEASES (2022)

Article Multidisciplinary Sciences

Effectiveness of COVID-19 vaccines against Omicron and Delta hospitalisation, a test negative case-control study

Julia Stowe et al.

Summary: This study estimated the vaccine effectiveness (VE) against hospitalization with the Omicron and Delta variants using PCR testing linked to hospital records, and showed that VE estimates increase with the use of specific hospitalization definitions.

NATURE COMMUNICATIONS (2022)

Letter Infectious Diseases

Hospitalisation associated with SARS-CoV-2 delta variant in Denmark

Peter Bager et al.

LANCET INFECTIOUS DISEASES (2021)

Article Multidisciplinary Sciences

Increased risk of hospitalisation and intensive care admission associated with reported cases of SARS-CoV-2 variants B.1.1.7 and B.1.351 in Norway, December 2020-May 2021

Lamprini Veneti et al.

Summary: This study in Norway found that the B.1.1.7 and B.1.351 variants of concern were associated with an increased risk of hospitalisation and admission to ICU compared to non-VOC. The findings underscore the importance of prevention, vaccination, and hospital surge capacity planning in combating the spread of these variants.

PLOS ONE (2021)

Article Infectious Diseases

Risk of hospitalisation associated with infection with SARS-CoV-2 lineage B.1.1.7 in Denmark: an observational cohort study

Peter Bager et al.

Summary: The study conducted in Denmark found that individuals infected with the B.1.1.7 lineage of SARS-CoV-2 had a higher risk of hospitalisation for COVID-19 compared to those with other lineages. While the overall number of hospitalisations decreased during the study period, the proportion of individuals infected with B.1.1.7 significantly increased. The findings suggest implications for hospital preparedness and understanding the impact of the epidemic in areas with the dominant presence of B.1.1.7.

LANCET INFECTIOUS DISEASES (2021)

Article Medicine, General & Internal

Risk of hospital admission for patients with SARS-CoV-2 variant B.1.1.7: cohort analysis

Tommy Nyberg et al.

Summary: The study evaluated the relationship between Covid-19 diagnosis and the B.1.1.7 variant of concern, finding a higher risk of hospital admission for individuals infected with the B.1.1.7 variant compared to wild-type SARS-CoV-2. This increased risk of severity may be specific to adults older than 30 years.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Article Multidisciplinary Sciences

Collider bias undermines our understanding of COVID-19 disease risk and severity

Gareth J. Griffith et al.

NATURE COMMUNICATIONS (2020)